Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future Directions

Sheena Bhalla; Douglas Tremblay; John Mascarenhas

doi:10.1016/j.clml.2016.06.012

Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future Directions

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2016.06.012 ◽

2016 ◽

Vol 16 (9) ◽

pp. 488-494 ◽

Cited By ~ 6

Author(s):

Sheena Bhalla ◽

Douglas Tremblay ◽

John Mascarenhas

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Chronic Myelogenous Leukemia ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Myelogenous Leukemia ◽

Current Understanding ◽

Future Directions ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Blood Cancer Journal ◽

10.1038/bcj.2016.27 ◽

2016 ◽

Vol 6 (5) ◽

pp. e418-e418 ◽

Cited By ~ 6

Author(s):

Z Chen ◽

W Wang ◽

J E Cortes ◽

E Liu ◽

R N Miranda ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Chronic Myelogenous Leukemia ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Myeloid Sarcoma ◽

Myelogenous Leukemia ◽

Prognostic Impact ◽

Blast Phase ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

The complexity of growth failure in children receiving tyrosine kinase inhibitor therapy for chronic myelogenous leukemia

Pediatric Blood & Cancer ◽

10.1002/pbc.26703 ◽

2017 ◽

Vol 64 (12) ◽

pp. e26703 ◽

Cited By ~ 3

Author(s):

Jill Samis ◽

Paul Lee ◽

Donald Zimmerman ◽

Meinolf Suttorp ◽

Nobuko Hijiya

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Chronic Myelogenous Leukemia ◽

Kinase Inhibitor ◽

Growth Failure ◽

Inhibitor Therapy ◽

Myelogenous Leukemia ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy

Pediatric Blood & Cancer ◽

10.1002/pbc.22945 ◽

2010 ◽

Vol 56 (4) ◽

pp. 671-673 ◽

Cited By ~ 35

Author(s):

Susan L. Hobernicht ◽

Bahareh Schweiger ◽

Philip Zeitler ◽

Michael Wang ◽

Stephen P. Hunger

Keyword(s):

Growth Hormone ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Growth Hormone Deficiency ◽

Chronic Myelogenous Leukemia ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Myelogenous Leukemia ◽

Hormone Deficiency ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Association between regular molecular monitoring and tyrosine kinase inhibitor therapy adherence in chronic myelogenous leukemia in the chronic phase

Current Medical Research and Opinion ◽

10.1185/03007995.2014.904281 ◽

2014 ◽

Vol 30 (7) ◽

pp. 1345-1352 ◽

Cited By ~ 24

Author(s):

Annie Guérin ◽

Lei Chen ◽

Katherine Dea ◽

Eric Q. Wu ◽

Stuart L. Goldberg

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Chronic Myelogenous Leukemia ◽

Kinase Inhibitor ◽

Chronic Phase ◽

Inhibitor Therapy ◽

Myelogenous Leukemia ◽

Molecular Monitoring ◽

Therapy Adherence ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Chronic Myelogenous Leukemia: Pregnancy in the Era of Stopping Tyrosine Kinase Inhibitor Therapy

Journal of Clinical Oncology ◽

10.1200/jco.2017.77.2574 ◽

2018 ◽

Vol 36 (12) ◽

pp. 1250-1256 ◽

Cited By ~ 15

Author(s):

Ellin Berman ◽

Brian J. Druker ◽

Richard Burwick

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Chronic Myelogenous Leukemia ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Myelogenous Leukemia ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Principles and Current Topics Concerning Management of Tyrosine Kinase Inhibitor Therapy for Chronic Myelogenous Leukemia

Translational Medicine ◽

10.4172/2161-1025.s2-001 ◽

2013 ◽

Vol 01 (S2) ◽

Author(s):

Junya Kuroda

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Chronic Myelogenous Leukemia ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Myelogenous Leukemia ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Faculty Opinions recommendation of Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726230050.793523214 ◽

2016 ◽

Author(s):

Ruediger Hehlmann

Keyword(s):

Risk Stratification ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Chronic Myelogenous Leukemia ◽

Kinase Inhibitor ◽

Chromosomal Abnormalities ◽

Inhibitor Therapy ◽

Myelogenous Leukemia ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia

Pediatric Blood & Cancer ◽

10.1002/pbc.26028 ◽

2016 ◽

Vol 63 (8) ◽

pp. 1332-1338 ◽

Cited By ~ 23

Author(s):

Jill Samis ◽

Paul Lee ◽

Donald Zimmerman ◽

Robert J. Arceci ◽

Meinolf Suttorp ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Chronic Myelogenous Leukemia ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Myelogenous Leukemia ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy

Haematologica ◽

10.3324/haematol.2011.056721 ◽

2012 ◽

Vol 97 (7) ◽

pp. 1029-1035 ◽

Cited By ~ 47

Author(s):

N. Pemmaraju ◽

H. Kantarjian ◽

J. Shan ◽

E. Jabbour ◽

A. Quintas-Cardama ◽

...

Keyword(s):

Young Adults ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Chronic Myelogenous Leukemia ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Myelogenous Leukemia ◽

Adolescents And Young Adults ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

TheBCR–ABL1T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy

Leukemia & Lymphoma ◽

10.3109/10428194.2012.762649 ◽

2013 ◽

Vol 54 (9) ◽

pp. 2083-2087 ◽

Cited By ~ 1

Author(s):

Jitka Malcikova ◽

Filip Razga ◽

Tomas Jurcek ◽

Dana Dvorakova ◽

Daniela Zackova ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Disease Progression ◽

Chronic Myelogenous Leukemia ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Myelogenous Leukemia ◽

Tyrosine Kinase Inhibitor Therapy ◽

Genomic Aberrations

Download Full-text